Chairperson: Vincent T. Armenti, Thomas Jefferson University
1:00 PM–1:15 PM
Introduction
Vincent T. Armenti, Thomas Jefferson University
1:15 PM–2:15 PM
Use of Control Groups
Moderator: Vincent T. Armenti, Thomas Jefferson University
1:15 PM–1:45 PM
W1
Controls for Pregnancy Registry
Lewis B. Holmes, MassGeneral Hospital for Children
1:45 PM–1:55 PM
W2
A Sample Size Calculation Method for Spontaneous Abortion in Observational Studies Xu R, Chambers C. University of California, San Diego, La Jolla, CA, United States.
1:55 PM–2:05 PM
W3
The Xolair Pregnancy Registry (EXPECT): Design of an Observational Study of Safety of (Omalizumab) During Pregnancy in Women With Asthma Namazy J1, Miller MK2, Wang V2, Gershman A2, Andrews E3. 1Scripps Clinic, San Diego, CA, United States, 2Genentech, Inc., South San Francisco, United States, 3RTI Health Solutions, Research Triangle Park, United States.
2:05 PM–2:15 PM
W4
National Transplantation Pregnancy Registry (NTPR): The Use of an Internal Control Group to Identify a Specific Pattern of Malformation Termini SM, Helms MC, Coscia LA, McGrory CH, Armenti VT. Thomas Jefferson University, Philadelphia, PA, United States.
2:15 PM–3:50 PM
Inclusion/Exclusion of Specific Cardiac Defects in Birth Defects Research
Moderator: Kenneth Lyons Jones, University of California, San Diego
2:15 PM–2:45 PM
W5
Selecting Congenital Heart Defects in Birth Defects Research: Biology vs. Budget
Angela Lin, Genetics Unit, Mass General Hospital for Children
2:45 PM–2:55 PM
W6
Pregnancy Outcome and Fetal Malformation Risk of Women with Epilepsy: Pregnancy Registry Based Experience from Kerala, India Thomas SV, Syam UK, Asha PT, Sucharitha DJ, Sabarinathan S, Sarma PS. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala State, India.
2:55 PM–3:05 PM
W7
Using ICD-9 Codes in Discharge Diagnoses to Establish Prevalence of Malformations in Newborn Infants Holmes LB, Westgate M-N. MassGeneral Hospital for Children, Boston, MA, United States.
3:05 PM–3:20 PM
Break
3:20 PM–3:30 PM
W9
Evaluation of Congenital Defect Rates from an Insurance Claims Database and an Electronic Health Record Database: Comparison to US National Prevalence Estimates Wurst KE, Ephross SA. GlaxoSmithKline, Research Triangle Park, NC, United States.
3:30 PM–3:40 PM
W10
Lost to Follow-up Classification and Analytic Implications in Pregnancy Exposure Registries Covington DL, McKain LF, Golembesky A, Churchill P. PPD, Inc., Wilmington, NC, United States.
3:40 PM–4:40 PM
Communicating Risks to the Public
Moderator: Dee L. Quinn, University of Arizona
3:40 PM – 4:10 PM
W11
Communicating Risks to the Public
Jan M. Friedman, University of British Columbia
4:10 PM–4:20 PM
W12
Pregnancy Drug Safety Information and Surveillance for Type 2 Diabetes Drugs McKain LF, Covington DL. PPD, Inc., Wilmington, NC, United States
4:20 PM–4:30 PM
W13
Pregnant Women’s Feelings toward Flu Vaccination While Breastfeeding Gorman JR, Chambers CD. University of California San Diego, La Jolla, CA, United States.
4:30 PM–4:40 PM
W14
Newsome K1, Williams J2, Rasmussen SA2, Callaghan W3, McIntyre A4, Hill H5, Way S1, Honein M2, Jamieson D3, Zotti M3, Finelli L4.1SciMetrika LLC, Research Triangle Park, NC, United States, 2National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, GA, United States, 3National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, United States, 4National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States, 5RTI International, Research Triangle Park, NC, United States. Infant Outcomes among Critically Ill Pregnant Women with Laboratory-Confirmed Influenza during the 2009 H1N1 Influenza Pandemic Sonja A. Rasmussen, Centers for Disease Control and Prevention
1:30 PM–4:45 PM
Education Course: From Bench to Community: Methods for Identification of Novel Teratogens (Separate Registration Required)—Commodore Ballroom E
Meeting Information
